课题基金 / 基金详情

CSF IGG ANALYSIS IN MULTIPLE SCLEROSIS

CSF IGG ANALYSIS IN MULTIPLE SCLEROSIS
多发性硬化症的 CSF IGG 分析
批准号:
3400594
负责人:
Richard Alan Rudick
金额:
$7.83万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1984
资助国家:
美国
项目状态:
已结题
起止时间:
1984-07-01 至 1988-06-30

项目摘要

项目成果

Richard Alan Rudick的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Demyelination in Multiple Sclerosis (MS) results from an inflammatory process that appears to be immune mediated. The antigen(s) which initiate or sustain injury are unknown. We propose to characterize soluble immune complexes (ICx) that have been isolated from the cerebrospinal fluid (CSF) of patients with MS and other neurological disordes. Soluble ICx will be isolated in the fluid phase with ferritin conjugates of 125I-labeled monoclonal anti-IgG antibodies (anti-IgG-F). The high density of the ferrintin increases the effective s-rate of soluble ICx while its characteristic appearance simultaneously provides an ultrastructural marker for the ICx. Electron microscopy will be performed using negative staining techniques to improve macromolecular detail and with the hope that clues regarding the nature of putative antigens will be forthcoming, especially if relevant antigens are of viral origin. Antigen within soluble immune complexes will be analyzed utilizing polyacrylamide gel electrophoresis coupled with immunologic staining of "blots" of protein separated by SDS-PAGE. Similar assays will be used to show the presence of antibodies within CSF that are directed to the individual protein bands. Finally, monoclonal antibodies will be raised to separated soluble ICx and screened for their reactivity with ICx and eventually the various bands separated by electrophoresis, again with the "Western Blot" technique. By these studies, we hope to determine important physical and biochemical properties of antigens that may have pathogenic significance in MS and other neurological diseases. Ultimately, this should lead to new and specific strategies for immunotherapy.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
BIOMARKERS OF THE THERAPUETIC RESPONSE TO INTERFERON IN MULTIPLE SCLEROSIS
  • 批准号:
    7608185
  • 项目类别:
  • 资助金额:
    $5.8万
  • 财政年份:
    2007
  • 负责人:
    Richard Alan Rudick
  • 依托单位:
BIOMARKERS OF THE THERAPUETIC RESPONSE TO INTERFERON IN MULTIPLE SCLEROSIS
  • 批准号:
    7377709
  • 项目类别:
  • 资助金额:
    $69.39万
  • 财政年份:
    2006
  • 负责人:
    Richard Alan Rudick
  • 依托单位:
BIOMARKERS OF THE THERAPEUTIC RESPONSE TO INTERFERON IN MULTIPLE SCLEROSIS
  • 批准号:
    7203224
  • 项目类别:
  • 资助金额:
    $5.5万
  • 财政年份:
    2005
  • 负责人:
    Richard Alan Rudick
  • 依托单位:
Cleveland Clinic Clinical Research Training Program(RMI)
  • 批准号:
    7169518
  • 项目类别:
  • 资助金额:
    $315.85万
  • 财政年份:
    2004
  • 负责人:
    Richard Alan Rudick
  • 依托单位:
海外基金